Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (2,199)	$ 377
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock based compensation	2,889	4,624
Amortization of debt issuance costs and discounts	87	68
Provision for expected losses	1,823	2,519
Provision for inventory reserve	25	334
Depreciation and amortization included in operating expenses	5,029	3,197
Depreciation included in costs of sales for rental equipment	852	738
Other	6	402
Changes in operating assets and liabilities:
Accounts receivable	9,589	(4,415)
Finance receivables	(653)	(627)
Inventory	(8,245)	(8,691)
Prepaid expenses and other assets	(746)	(1,909)
Accounts payable and accrued expenses	(2,868)	(206)
Operating lease liabilities	183	(547)
Deferred revenue	1	207
Net cash provided by (used in) operating activities	5,773	(3,929)
Cash flows from investing activities:
Acquisition of business, net of cash acquired	(35,855)	(2,966)
Purchase of property and equipment	(12,634)	(7,198)
Net cash used in investing activities	(48,489)	(10,164)
Cash flows from financing activities:
Payment of third-party debt issuance costs	0	(107)
Proceeds from long-term debt	25,000	738
Repayment of long-term debt	(580)	(437)
Contingent consideration paid for acquisition	(1,000)	0
Proceeds from exercise of common stock options	0	849
Repurchase of Series A Convertible Preferred Stock	(2,153)	0
Net cash provided by financing activities	21,267	1,043
Net decrease in cash and cash equivalents	(21,449)	(13,050)
Cash and cash equivalents at beginning of year	68,125	88,136
Cash and cash equivalents at end of period	46,676	75,086
Supplemental disclosures of cash flow information:
Interest paid in cash	1,869	542
Common stock issued in business combination	3,942	0
Non-cash activity:
Lease assets obtained in exchange for new operating lease liabilities	$ 0	$ 471